重庆医学
重慶醫學
중경의학
Chongqing Medicine
2015年
32期
4532-4534,4537
,共4页
胸苷激酶%鼻咽肿瘤%病理
胸苷激酶%鼻嚥腫瘤%病理
흉감격매%비인종류%병리
thymidine kinase%nasopharyngeal neoplasms%pathology
目的:考察血清胸苷激酶‐1(TK1)在鼻咽癌患者治疗过程的变化及与病理学特征的关系。方法收集该院2010~2013年在放疗科收治的鼻咽癌患者35例,选择同期鼻咽部炎症患者20例为对照。比较治疗前后血清T K1水平。结果治疗前后,对照组TK1无显著变化(P>0.05);与对照组比,治疗前后鼻咽癌组的TK1均较高(P<0.05);与治疗前比,治疗后鼻咽癌组的TK1显著降低(P<0.05)。治疗前后,鼻咽癌Ⅰ~Ⅱ期的TK1均低于Ⅲ~Ⅳ期(P<0.05),无淋巴结转移均低于淋巴结转移(P<0.05),颈神经未侵犯低于颈神经侵犯(P<0.05),颅底未受侵低于颅底受侵(P<0.05),未分化癌高于高中分化鳞癌和低分化鳞癌(P<0.05)。TNM Ⅳ期、淋巴结转移、颈神经侵犯TK1表达较高(P<0.05)。结论 TK1可反映鼻咽癌患者的肿瘤负荷和增殖活性,对鼻咽癌诊断、监测病情和预后有应用前景。
目的:攷察血清胸苷激酶‐1(TK1)在鼻嚥癌患者治療過程的變化及與病理學特徵的關繫。方法收集該院2010~2013年在放療科收治的鼻嚥癌患者35例,選擇同期鼻嚥部炎癥患者20例為對照。比較治療前後血清T K1水平。結果治療前後,對照組TK1無顯著變化(P>0.05);與對照組比,治療前後鼻嚥癌組的TK1均較高(P<0.05);與治療前比,治療後鼻嚥癌組的TK1顯著降低(P<0.05)。治療前後,鼻嚥癌Ⅰ~Ⅱ期的TK1均低于Ⅲ~Ⅳ期(P<0.05),無淋巴結轉移均低于淋巴結轉移(P<0.05),頸神經未侵犯低于頸神經侵犯(P<0.05),顱底未受侵低于顱底受侵(P<0.05),未分化癌高于高中分化鱗癌和低分化鱗癌(P<0.05)。TNM Ⅳ期、淋巴結轉移、頸神經侵犯TK1錶達較高(P<0.05)。結論 TK1可反映鼻嚥癌患者的腫瘤負荷和增殖活性,對鼻嚥癌診斷、鑑測病情和預後有應用前景。
목적:고찰혈청흉감격매‐1(TK1)재비인암환자치료과정적변화급여병이학특정적관계。방법수집해원2010~2013년재방료과수치적비인암환자35례,선택동기비인부염증환자20례위대조。비교치료전후혈청T K1수평。결과치료전후,대조조TK1무현저변화(P>0.05);여대조조비,치료전후비인암조적TK1균교고(P<0.05);여치료전비,치료후비인암조적TK1현저강저(P<0.05)。치료전후,비인암Ⅰ~Ⅱ기적TK1균저우Ⅲ~Ⅳ기(P<0.05),무림파결전이균저우림파결전이(P<0.05),경신경미침범저우경신경침범(P<0.05),로저미수침저우로저수침(P<0.05),미분화암고우고중분화린암화저분화린암(P<0.05)。TNM Ⅳ기、림파결전이、경신경침범TK1표체교고(P<0.05)。결론 TK1가반영비인암환자적종류부하화증식활성,대비인암진단、감측병정화예후유응용전경。
Objective To learn the change of serum thymidine Kinase 1(TK1) level in the treatment process of the early cure nasopharyngeal carcinoma patients and its relationship to pathological features .Methods From January 2010 to December 2013 ,35 cases of nasopharyngeal carcinoma patients were collected into our study ,20 cases of nasopharyngeal inflammation patients were chosen as the control .Serum TK1 level in the 2 groups was compared before and after treatment .Results TK1 in control group had no significant differences before and after treatment (P>0 .05) .Compared with the control group ,serum TK1 in nasopharyngeal carcinoma group were higher before and after radiotherapy (P<0 .05);after radiotherapy ,serums TK1 in nasopharyngeal carcinoma group were lower(P<0 .05) .Before and after radiotherapy ,serum TK1 Ⅰ and Ⅱ stage were lower than in Ⅲ and Ⅳ stager(P<0 .05) ,lymph node metastasis group were higher than no lymph node metastasisr (P<0 .05) ,TK1 had higher expression in TNMⅣ than TNM Ⅱ(P<0 .05) ,compared with lymph node metastasis and cervical nerve violated groups ,TK1 expression was higher in none lymph node metastasis and none cervical nerve violated groups (P<0 .05) .Conclusion TK1 can reflect the tumor load and proliferative activity of nasopharyngeal carcinoma ,which could be as a factor in nasopharyngeal carcinoma diagnosis ,monitoring and prognosis .